ALS drug trial halted early: did lithium fail?
Disease control
Terminated
This phase 3 trial tested lithium carbonate against placebo in 88 people with ALS to see if it could improve survival and daily function. The study was terminated early, so the full results are not available. The trial aimed to find a treatment that slows the disease, but its ear…
Phase: PHASE3 • Sponsor: Stichting TRICALS Foundation • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC